Eric Borges

3.3k total citations · 1 hit paper
28 papers, 2.7k citations indexed

About

Eric Borges is a scholar working on Immunology and Allergy, Immunology and Molecular Biology. According to data from OpenAlex, Eric Borges has authored 28 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology and Allergy, 13 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Eric Borges's work include Cell Adhesion Molecules Research (15 papers), Immunotherapy and Immune Responses (8 papers) and Protease and Inhibitor Mechanisms (7 papers). Eric Borges is often cited by papers focused on Cell Adhesion Molecules Research (15 papers), Immunotherapy and Immune Responses (8 papers) and Protease and Inhibitor Mechanisms (7 papers). Eric Borges collaborates with scholars based in Germany, United States and Austria. Eric Borges's co-authors include Dietmar Vestweber, Alf Hamann, Martin Steegmaier, Rupert Hallmann, Erkki Ruoslahti, Harald Renz, F Austrup, Alexander Scheffold, Udo Herz and Max Löhning and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Eric Borges

28 papers receiving 2.7k citations

Hit Papers

P- and E-selectin mediate recruitment of T-helper-1 but n... 1997 2026 2006 2016 1997 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Borges Germany 18 1.4k 1.3k 966 599 323 28 2.7k
T K Kishimoto United States 18 1.3k 1.0× 1.6k 1.3× 656 0.7× 272 0.5× 317 1.0× 23 2.4k
R A Warnock United States 11 1.9k 1.4× 1.9k 1.5× 756 0.8× 538 0.9× 445 1.4× 12 3.2k
M. Nicotra Italy 26 1.1k 0.8× 689 0.5× 1.1k 1.1× 785 1.3× 495 1.5× 70 3.0k
Mark S. Singer United States 22 1.6k 1.2× 1.7k 1.3× 1.7k 1.7× 393 0.7× 469 1.5× 33 3.4k
Nancy Oppenheimer‐Marks United States 24 1.2k 0.9× 986 0.8× 499 0.5× 350 0.6× 437 1.4× 33 2.3k
Sandra Isenmann Australia 19 673 0.5× 872 0.7× 1.2k 1.2× 309 0.5× 154 0.5× 23 2.2k
Ed Roos Netherlands 31 946 0.7× 849 0.7× 1.1k 1.1× 1.1k 1.8× 407 1.3× 74 2.7k
Jianghai Zhu United States 16 539 0.4× 1.1k 0.9× 1.1k 1.1× 313 0.5× 336 1.0× 19 2.5k
T. Venkat Gopal United States 11 873 0.6× 993 0.8× 811 0.8× 210 0.4× 365 1.1× 15 2.1k
Albert J.W. Zendman Netherlands 21 768 0.6× 422 0.3× 1.0k 1.1× 528 0.9× 563 1.7× 26 2.8k

Countries citing papers authored by Eric Borges

Since Specialization
Citations

This map shows the geographic impact of Eric Borges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Borges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Borges more than expected).

Fields of papers citing papers by Eric Borges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Borges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Borges. The network helps show where Eric Borges may publish in the future.

Co-authorship network of co-authors of Eric Borges

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Borges. A scholar is included among the top collaborators of Eric Borges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Borges. Eric Borges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Friedbichler, Katrin, Marco H. Hofmann, Elínborg Ostermann, et al.. (2013). Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin. Molecular Cancer Therapeutics. 13(2). 399–409. 73 indexed citations
3.
Adam, Paul J., Katrin Friedbichler, Marco H. Hofmann, et al.. (2012). BI 836845, a fully human IGF ligand neutralizing antibody, to improve the efficacy of rapamycin by blocking rapamycin-induced AKT activation.. Journal of Clinical Oncology. 30(15_suppl). 3092–3092. 4 indexed citations
4.
Adam, Paul J., Elínborg Ostermann, Herbert R. Lamche, et al.. (2011). Abstract A208: Pharmacodynamic properties and antitumor efficacy of BI 836845, a fully human IGF ligand neutralizing antibody.. Molecular Cancer Therapeutics. 10(11_Supplement). A208–A208. 2 indexed citations
5.
Treder, Martin, Susanne Hartmann, Eric Borges, et al.. (2008). Fully human Anti-HER3 monoclonal antibodies (mAbs) inhibit oncogenic signaling and tumor cell growth in vitro and in vivo. 68. 14 indexed citations
6.
Pendl, Gunther G., Caroline Robert, Meike Steinert, et al.. (2002). Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. Blood. 99(3). 946–956. 64 indexed citations
7.
Pendl, Gunther G., Caroline Robert, Meike Steinert, et al.. (2002). Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. Blood. 99(3). 946–956. 12 indexed citations
8.
Gerlag, Daniëlle M., Eric Borges, Paul P. Tak, et al.. (2001). Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Research & Therapy. 3(6). 357–61. 87 indexed citations
9.
Borges, Eric, et al.. (2000). Platelet-derived Growth Factor Receptor β and Vascular Endothelial Growth Factor Receptor 2 Bind to the β3Integrin through Its Extracellular Domain. Journal of Biological Chemistry. 275(51). 39867–39873. 240 indexed citations
10.
Montoya, Marı́a C., Karen R. Snapp, Eric Borges, et al.. (1999). Memory B lymphocytes from secondary lymphoid organs interact with E-selectin through a novel glycoprotein ligand. Journal of Clinical Investigation. 103(9). 1317–1327. 21 indexed citations
11.
Tietz, W, et al.. (1998). CD4+ T Cells Migrate into Inflamed Skin Only If They Express Ligands for E- and P-Selectin. The Journal of Immunology. 161(2). 963–970. 150 indexed citations
12.
Borges, Eric, W Tietz, Martin Steegmaier, et al.. (1997). P-Selectin Glycoprotein Ligand-1 (PSGL-1) on T Helper 1 but Not on T Helper 2 Cells Binds to P-Selectin and Supports Migration into Inflamed Skin. The Journal of Experimental Medicine. 185(3). 573–578. 236 indexed citations
13.
Borges, Eric, et al.. (1997). The Binding of T Cell-expressed P-selectin Glycoprotein Ligand-1 to E- and P-selectin Is Differentially Regulated. Journal of Biological Chemistry. 272(45). 28786–28792. 95 indexed citations
14.
Austrup, F, Dietmar Vestweber, Eric Borges, et al.. (1997). P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature. 385(6611). 81–83. 637 indexed citations breakdown →
15.
Steegmaier, Martin, et al.. (1997). P‐selectin glycoprotein ligand‐1 mediates rolling of mouse bone marrow‐derived mast cells on P‐selectin but not efficiently on E‐selectin. European Journal of Immunology. 27(6). 1339–1345. 25 indexed citations
16.
Steegmaier, Martin, et al.. (1997). The E-selectin-ligand ESL-1 is located in the Golgi as well as on microvilli on the cell surface. Journal of Cell Science. 110(6). 687–694. 63 indexed citations
17.
Borges, Eric, et al.. (1997). VE-cadherin antibody accelerates neutrophil recruitment in vivo. Journal of Cell Science. 110(5). 583–588. 267 indexed citations
18.
Borges, Eric, Ruth Eytner, Thomas Moll, et al.. (1997). The P-Selectin Glycoprotein Ligand-1 Is Important for Recruitment of Neutrophils Into Inflamed Mouse Peritoneum. Blood. 90(5). 1934–1942. 103 indexed citations
19.
Levinovitz, Agneta, Sandra Isenmann, Eric Borges, et al.. (1995). The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature. 373(6515). 615–620. 275 indexed citations
20.
Borges, Eric, Karl‐Heinz Wiesmüller, Günther Jung, & Peter Walden. (1994). Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes comparison of the costimulating support provided by helper T cells and lipoamino acid. Journal of Immunological Methods. 173(2). 253–263. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026